MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from issuance of shares...
Prepaid expenses and other curre...
Negative Cash Flow Breakdown
Purchase of short-term investmen...
Accounts payable and other curre...
Stock-based compensation
Issuance costs
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,794,863
-2,541,070
-8,112,450
-2,975,117
Stock-based compensation
-64,283
227,180
785,814
150,614
Change in fair value of convertible promissory notes
-
-
-2,306,842
1,941,124
Warrant repricing
0
410,154
-
-
Prepaid expenses and other current assets
-249,085
-119,319
-203,386
357,997
Accounts payable and other current liabilities
-317,573
-5,225,576
1,764,780
1,084,078
Operating lease right-of-use asset and liability, net
-
-
-199
-597
Net cash used in operating activities
-1,927,634
-7,009,993
-3,190,513
-2,567,427
Purchase of short-term investments
4,000,000
-
-
-
Proceeds from issuance of convertible promissory notes
-
-
0
0
Net cash used in investing activities
-4,000,000
-
-
-
Proceeds from issuance of shares of common stock and warrants
12,000,000
-
0
2,339,169
Proceeds from issuance of preferred stock
-
-
6,000,000
-
Proceeds from exercise of pre-funded warrants
-
-
1,754
154
Issuance costs
16,181
-
129,252
103,958
Net cash provided by financing activities
11,983,819
-
5,872,502
2,235,365
Net change in cash and cash equivalents
6,056,185
-7,009,993
2,681,989
-332,062
Cash and cash equivalents, beginning of period
1,497,635
8,507,628
5,825,639
5,786,753
Cash and cash equivalents, end of period
7,553,820
1,497,635
8,507,628
5,825,639
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
shares of common stock...
$12,000,000
(195.73%↑ Y/Y)
Net cash provided by
financing activities
$11,983,819
(27.00%↑ Y/Y)
Canceled cashflow
$16,181
Net change in cash
and cash...
$6,056,185
(1532.62%↑ Y/Y)
Canceled cashflow
$5,927,634
Issuance costs
$16,181
(-95.19%↓ Y/Y)
Prepaid expenses and
other current assets
-$249,085
(69.69%↑ Y/Y)
Net cash used in
investing activities
-$4,000,000
Net cash used in
operating activities
-$1,927,634
(78.74%↑ Y/Y)
Canceled cashflow
$249,085
Purchase of short-term
investments
$4,000,000
Net loss
-$1,794,863
(81.61%↑ Y/Y)
Accounts payable and
other current...
-$317,573
(-123.81%↓ Y/Y)
Stock-based compensation
-$64,283
(-115.25%↓ Y/Y)
Buy us a coffee
Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc. (INDP)